Literature DB >> 30944239

Effects of Lewy body disease and Alzheimer disease on brain atrophy and cognitive dysfunction.

Sung Woo Kang1, Seun Jeon1, Han Soo Yoo1, Seok Jong Chung1, Phil Hyu Lee1, Young H Sohn1, Mijin Yun1, Alan C Evans1, Byoung Seok Ye2.   

Abstract

OBJECTIVES: To investigate the independent and interaction effects of Alzheimer disease (AD) and Lewy body disease (LBD) on cognition and brain atrophy.
METHODS: We consecutively recruited 38 controls and 108 patients with AD-related cognitive impairment (ADCI) and/or LBD-related cognitive impairment (LBCI) from university-based dementia and movement clinics. Diagnoses of ADCI and LBCI were supported by 18F-florbetaben PET and 18F-N-(3-fluoropropyl)-2β-carbon ethoxy-3β-(4-iodophenyl) nortropane-PET, respectively. There were 38 controls, 26 patients with pure ADCI (18 mild cognitive impairment [MCI] and 8 dementia), 28 patients with pure LBCI (13 MCI and 15 dementia), and 54 patients with mixed ADCI and LBCI (17 MCI and 37 dementia). We performed group-wise comparisons for neuropsychological z scores and regional cortical thickness. We also evaluated the effects of ADCI and LBCI using general linear models.
RESULTS: Compared to the controls, patients in the pure ADCI group and pure LBCI group had focused cortical thinning in the bilateral entorhinal/right anterior temporal cortices and bilateral anteromedial temporal/basal frontal cortices, respectively, while the mixed disease group had additional cortical thinning in the widespread association cortices. The independent effects of ADCI and LBCI on regional cortical thinning overlapped in the widespread association cortices, especially at the bilateral temporoparietal junction and parietal cortices. ADCI and LBCI had independent detrimental effects on the copying item of the Rey-Osterrieth Complex Figure Test.
CONCLUSIONS: Concomitant ADCI and LBCI are associated with the accentuation of neurodegeneration to widespread association cortices, and both diseases contribute to visuospatial dysfunction.
© 2019 American Academy of Neurology.

Entities:  

Year:  2019        PMID: 30944239     DOI: 10.1212/WNL.0000000000007373

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  11 in total

1.  Effect Modifiers of TDP-43-Associated Hippocampal Atrophy Rates in Patients with Alzheimer's Disease Neuropathological Changes.

Authors:  Marina Buciuc; Alexandra M Wennberg; Stephen D Weigand; Melissa E Murray; Matthew L Senjem; Anthony J Spychalla; Bradley F Boeve; David S Knopman; Clifford R Jack; Kejal Kantarci; Joseph E Parisi; Dennis W Dickson; Ronald C Petersen; Jennifer L Whitwell; Keith A Josephs
Journal:  J Alzheimers Dis       Date:  2020       Impact factor: 4.472

Review 2.  Neuropathology and pathogenesis of extrapyramidal movement disorders: a critical update-I. Hypokinetic-rigid movement disorders.

Authors:  Kurt A Jellinger
Journal:  J Neural Transm (Vienna)       Date:  2019-06-18       Impact factor: 3.575

Review 3.  The Key Role of Magnetic Resonance Imaging in the Detection of Neurodegenerative Diseases-Associated Biomarkers: A Review.

Authors:  Ke-Ru Li; An-Guo Wu; Yong Tang; Xiao-Peng He; Chong-Lin Yu; Jian-Ming Wu; Guang-Qiang Hu; Lu Yu
Journal:  Mol Neurobiol       Date:  2022-07-12       Impact factor: 5.682

4.  Local cortical overexpression of human wild-type alpha-synuclein leads to increased dendritic spine density in mouse.

Authors:  Lucia M Wagner; Sheyna M Nathwani; Patrick P Ten Eyck; Georgina M Aldridge
Journal:  Neurosci Lett       Date:  2020-05-14       Impact factor: 3.046

5.  Structural connectivity networks in Alzheimer's disease and Lewy body disease.

Authors:  Kyoungwon Baik; Jin-Ju Yang; Jin Ho Jung; Yang Hyun Lee; Seok Jong Chung; Han Soo Yoo; Young H Sohn; Phil Hyu Lee; Jong-Min Lee; Byoung Seok Ye
Journal:  Brain Behav       Date:  2021-04-01       Impact factor: 2.708

6.  Topography of cortical thinning in the Lewy body diseases.

Authors:  Rong Ye; Alexandra Touroutoglou; Michael Brickhouse; Samantha Katz; John H Growdon; Keith A Johnson; Bradford C Dickerson; Stephen N Gomperts
Journal:  Neuroimage Clin       Date:  2020-01-31       Impact factor: 4.881

7.  Effects of Alzheimer's genetic risk scores and CSF biomarkers in de novo Parkinson's Disease.

Authors:  Young-Gun Lee; Seong Ho Jeong; Mincheol Park; Sung Woo Kang; Kyoungwon Baik; Seun Jeon; Phil Hyu Lee; Young Ho Sohn; Byoung Seok Ye
Journal:  NPJ Parkinsons Dis       Date:  2022-05-11

8.  Implication of metabolic and dopamine transporter PET in dementia with Lewy bodies.

Authors:  Sung Woo Kang; Seun Jeon; Young-Gun Lee; Mincheol Park; Kyoungwon Baik; Jin Ho Jung; Seok Jong Chung; Han Soo Yoo; Seong Ho Jeong; Mijin Yun; Phil Hyu Lee; Young H Sohn; Alan C Evans; Byoung Seok Ye
Journal:  Sci Rep       Date:  2021-07-13       Impact factor: 4.379

9.  Interaction of CSF α-synuclein and amyloid beta in cognition and cortical atrophy.

Authors:  Young-Gun Lee; Seun Jeon; Sung Woo Kang; Mincheol Park; Kyoungwon Baik; Han Soo Yoo; Seok Jong Chung; Seong Ho Jeong; Jin Ho Jung; Phil Hyu Lee; Young Ho Sohn; Alan C Evans; Byoung Seok Ye
Journal:  Alzheimers Dement (Amst)       Date:  2021-05-21

10.  Grey Matter Loss at Different Stages of Cognitive Decline: A Role for the Thalamus in Developing Alzheimer's Disease.

Authors:  Laurens Ansem van de Mortel; Rajat Mani Thomas; Guido Alexander van Wingen
Journal:  J Alzheimers Dis       Date:  2021       Impact factor: 4.472

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.